Comparative Pharmacology
Head-to-head clinical analysis: CHLOROMYCETIN HYDROCORTISONE versus FLONASE ALLERGY RELIEF.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROMYCETIN HYDROCORTISONE versus FLONASE ALLERGY RELIEF.
CHLOROMYCETIN HYDROCORTISONE vs FLONASE ALLERGY RELIEF
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chloromycetin (chloramphenicol) is a bacteriostatic antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation. Hydrocortisone is a corticosteroid that suppresses inflammation by inhibiting phospholipase A2 and reducing prostaglandin and leukotriene synthesis.
Glucocorticoid agonist; binds to glucocorticoid receptors, inhibiting inflammatory mediators (e.g., cytokines, prostaglandins) and reducing nasal mucosal inflammation.
Apply 1-2 drops or a small amount (approximately 0.5 cm ribbon) into the affected eye(s) every 3-4 hours, or more frequently as needed. For severe infections, may be used every 2 hours. Not to exceed 6 times daily. Otic: Instill 3-4 drops into the affected ear(s) 2-3 times daily.
2 sprays (50 mcg each) per nostril once daily, total daily dose 200 mcg. If inadequate, may increase to 2 sprays per nostril twice daily (400 mcg/day).
None Documented
None Documented
Chloramphenicol: 1.5-4 hours in adults with normal hepatic function; prolonged to 3-7 hours in neonates and up to 15 hours in severe liver disease. Hydrocortisone: 1-2 hours.
Terminal elimination half-life is approximately 10 hours (range 7–14 hours), reflecting slow release from tissue binding sites; accumulation occurs with once-daily dosing, achieving steady state in 1–2 weeks.
Renal: ~80-90% of chloramphenicol as inactive metabolites (glucuronide conjugate) and 5-10% unchanged. Biliary: <3% of unchanged drug. Fecal: minimal.
Primarily hepatic metabolism via CYP3A4; renal excretion accounts for <5% as unchanged drug, with the remainder as metabolites in feces (approximately 90%) and urine (approximately 5%).
Category D/X
Category C
Corticosteroid
Corticosteroid